Aimt stock yahoo finance

At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life. Back. Aimmune Therapeutics, Inc. (AIMT) Add to watchlist. NasdaqGS - … Aimmune Therapeutics, Inc. (AIMT) Stock Historical Prices ... Discover historical prices for AIMT stock on Yahoo Finance. View daily, weekly or monthly formats back to when Aimmune Therapeutics, Inc. stock was issued.

Stock quote and company snapshot for AIMMUNE THERAPEUTICS INC (AIMT), including profile, stock chart, recent news and events, analyst opinions, and  In depth view into AIMT (Aimmune Therapeutics) stock including the latest Independent Director Patrick Enright Just Bought Shares In Aimmune Therapeutics, Inc. (NASDAQ:AIMT). 03/22 08:06. Yahoo Cash from Financing ( TTM) 55.88M  Should you invest in Aimmune Therapeutics (NasdaqGS:AIMT)? Mediocre balance sheet Financial Health. How is Aimmune Therapeutics's financial position? Company Name: Aimmune Therapeutics, Stock Symbol: AIMT, Industry: #28, 

Apr 03, 2020 · Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.

Nov 05, 2019 · Aimmune Therapeutics, Inc. Overview: Detailed price quote, earnings report, user sentiment and news. Feb 14, 2020 Aimmune Therapeutics (AIMT) Stock Sinks As Market Gains: What You Should Know. Feb 13, 2020 Analysts Forecast Huge Upsides for Aimmune, Biohaven. Feb 10, 2020 Aimmune Therapeutics - AIMT - Stock Price & News | The ... Real time Aimmune Therapeutics (AIMT) stock price quote, stock graph, news & analysis. Latest Stock Picks The Ascent is The Motley Fool's new personal finance brand devoted to helping you live Biotech Stock Roundup: Earnings Updates From VRTX ... - Yahoo The Nasdaq Biotechnology index gained 1.03% in the last five trading sessions. Among the biotech giants, Gilead gained 4.72% in the period. Over the past six months, shares of Vertex have gained 36.51%. (See the last biotech stock roundup here: Biotech Stock Roundup: EPZM Drug Gets FDA Nod, XLRN & HEPA Surge on Study Data). Aimmune Therapeutics, Inc. (AIMT) Stock Analysis & News ...

Find the latest Aimmune Therapeutics, Inc. (AIMT) stock quote, history, news and other vital information to help you with your stock trading and investing.

Mar 27, 2020 · Add AIMT Price Alert Hide Sticky Hide Intro Moderator: Search This Board: 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003+ AIMT -- Is Its Stock Price A Worthy Investment? Learn More. Aimmune Therapeutics, Inc. (AIMT) Company Bio. Aimmune Therapeutics is a clinical-stage biopharmaceutical company, engages in the development of desensitization treatments for peanut and other food allergies. The company was founded in 2011 and is based in Brisbane, California. Best & Worst Performing Stock Industries for April 3, 2020. AIMT stock: Aimmune Therapeutics Inc - Super Stock Screener Aimmune Therapeutics Inc's stock rating is based on fundamental analysis. Don't miss AIMT stock next rating changes

Yahoo Finance on Yahoo

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

AIMMUNE AIMT Stock Surges In After-hours On FDA Approval February 1, 2020 by Lance Jepsen AIMT stock surged 16% in after-hours trading on January 31, 2020, after the …

AIMMUNE AIMT Stock Surges In After-hours On FDA Approval ... AIMMUNE AIMT Stock Surges In After-hours On FDA Approval February 1, 2020 by Lance Jepsen AIMT stock surged 16% in after-hours trading on January 31, 2020, after the … Earnings Whisper Number for AIMT: Aimmune Therap Aimmune Therap (AIMT) reports earnings on 5/28/2020. Shares are down 37.2% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. AIMT 13F Hedge Fund and Asset Management Owners 13F holdings: Abdiel, Dragoneer, Tiger Global and other top funds bought the stock's IPO in Q4. They're up 180% in 2 months. via whalewisdomalpha 02/20/2020; Here’s Whose Been Buying Tesla’s Stock During Its Massive Run-up 02/18/2020 Scion's Q4 2019 13F released.

AIMT:NASDAQ GS Stock Quote - Aimmune Therapeutics Inc ... Stock analysis for Aimmune Therapeutics Inc (AIMT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. AIMT - Aimmune Therap Stock Price - 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.